Anthropic priced its IPO at $83 a share on Wednesday night, above the $70 to $78 range. It sold about 980 million Class A shares, upsized from 825 million, of which about 956 million are new and about 24 million come from existing holders. That raises $81.3 billion, the largest IPO on record, ahead of the roughly $75 billion SpaceX took in June. Reports put the valuation at about $1.5 trillion. The stock starts trading on Nasdaq today as ANT, the deal closes Friday, and underwriters have 30 days to buy up to 147 million more shares.
Yesterday we wrote that the price was the number to watch, and that anything above $78 meant buyers were paying up for the $900.9 billion compute program as disclosed. They did. The book was reportedly about seven times covered.
The wrappers arrived first
What stands out is how fast the products around ANT showed up, some before a single share had traded.
Tradr ETFs said on November 16 that it expects to list two funds on Cboe on Monday, November 23, the second trading day after the IPO. The Tradr 2X Long Anthropic Daily ETF (ANTT) aims for twice the stock’s daily move, and the 2X Short (ANTZ) for minus twice. Both reset daily. Tradr hinted that ANT options may not exist yet at launch, which matters because leveraged single-stock funds usually build exposure with swaps and options. Its own warning says a 2x fund can lose everything if the stock moves more than 50% against it in a day. On an IPO’s first week, that isn’t a theoretical case.
FP Markets, the Cyprus-regulated broker, said ANT share CFDs would be tradable for its clients worldwide from today, on MetaTrader 5, cTrader and TradingView. So retail traders outside the US can take a leveraged position in Anthropic on day one, without owning a share and without an allocation.
None of this is new as a mechanism. Leveraged single-stock ETFs exist for Nvidia, Tesla and dozens of others, and CFDs on hot listings are routine outside the US. The speed is new. A $1.5 trillion company gets a leveraged ETF two trading days after listing, with the float still small and lockups months away. Early price discovery will run partly through instruments that magnify every move.
Cantor and the 13F problem
The same day, Cantor Fitzgerald put out a statement saying its Nvidia positions are hedges tied to client transactions, not material proprietary investments. The statement answers a CNBC analysis of Cantor’s 13F filings. Those showed more than 3.5 million Nvidia shares, worth about $479 million, at the end of 2024, falling to about 1.78 million by the end of March 2026. The firm, now run by the sons of Commerce Secretary Howard Lutnick, also reported put options on 1.5 million Nvidia shares. The scrutiny grew after Jensen Huang’s exit from Nvidia.
Whatever the politics, the explanation is plausible on its face. Most of the shares sat in a brokerage unit whose job is hedging client trades. A dealer that sells clients swaps or structured notes on Nvidia buys the stock to stay flat. When clients unwind, the dealer sells. A 13F shows only the long shares, not the short side or the swaps behind them, so a falling share count can mean clients got out, not that the firm turned bearish.
Why the two stories belong together
ANT will soon look the same. Every 2x fund, every swap a bank writes for a client and every CFD book a broker hedges needs someone to hold or short the underlying stock. Within a quarter, ANT’s 13F holder lists will be full of dealer hedges that look like conviction bets and aren’t.
The practical point for anyone reading flows in AI stocks: separate the owners from the plumbing. Index funds, long-only funds and insiders tell you what people think the company is worth. Dealer and ETF hedging tells you how much leverage sits on top of it. On Nvidia that layer took years to build. On Anthropic it is being built in the first week.
We read the wider AI market mood in our post on Nvidia’s quarter. The first test for ANT comes at the open. The second, and the bigger one, comes when the lockups end in the spring.